INOVIO Reports Fourth Quarter and Full Year 2022 Financial Results and Clinical Highlights

Announces topline results from REVEAL2, the second Phase 3 trial evaluating VGX-3100 as a treatment for cervical high-grade squamous intraepithelial lesions...

Related Keywords

United States ,American ,Jacqueline Shea ,Jennie Willson ,Thomas Hong ,Us Department Of Defense ,Drug Administration ,Inovio Pharmaceuticals Inc ,Esophageal Association ,Exchange Commission ,Delivery Technology ,Astrazeneca ,Pharmaceuticals Inc ,Clinical Cancer Research ,Recurrent Respiratory ,Chief Executive Officer ,Recurrent Respiratory Papillomatosis ,Annual Meeting ,American Broncho Esophageal Association ,Otolaryngology Spring Meetings ,Ebola Booster ,Overall Response Rate ,Annual Report ,Inovio Pharmaceuticals ,Nc ,